Globe Life Financial Statements (GL)

Globe Lifesmart-lab.ru   FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
Report date 07.05.2025 06.08.2025 05.11.2025 25.02.2026 07.05.2026   07.05.2026
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 1 480 1 481 1 513 1 524 1 560   6 078
Operating Income, bln rub 316.1 313.3 477.1 356.3 368.1   1 515
EBITDA, bln rub ? 351.1 348.2 513.2 379.3 368.1   1 609
Net profit, bln rub ? 254.6 252.7 387.8 266.0 270.5   1 177
OCF, bln rub ? 431.9 307.9 306.0 350.6 420.9   1 385
CAPEX, bln rub ? 11.7 12.9 97.3 20.5 24.9   155.6
FCF, bln rub ? 420.1 295.0 208.7 330.1 396.0   1 230
Dividend payout, bln rub 20.1 22.4 21.9 21.7 21.4   87.3
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 7.91% 8.85% 5.64% 8.15% 7.90%   7.41%
OPEX, bln rub 143.7 143.2 147.7 106.4 401.9   799.1
Cost of production, bln rub 1 021 1 025 888.2 1 061 789.6   3 764
R&D, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Interest expenses, bln rub 35.0 34.9 36.1 35.2 34.0   140.2
Assets, bln rub 29 705 29 809 30 528 30 814 30 966   30 966
Net Assets, bln rub ? 5 425 5 419 5 689 5 975 6 085   6 085
Debt, bln rub 2 802 2 790 2 714 2 625 2 779   2 779
Cash, bln rub 17 871 17 721 18 162 18 049 439.0   439.0
Net debt, bln rub -15 069 -14 931 -15 448 -15 423 2 340   2 340
Ordinary share price, rub 131.7 124.3 143.0 139.9 139.2   139.2
Number of ordinary shares, mln 83.5 83.5 83.5 80.9 78.4   78.4
Market cap, bln rub 10 996 10 376 11 935 11 308 10 913   10 913
EV, bln rub ? -4 073 -4 555 -3 513 -4 115 13 252   13 252
Book value, bln rub -1 689 -1 826 -1 674 -1 515 5 594   5 594
EPS, rub ? 3.05 3.03 4.65 3.29 3.45   15.0
FCF/share, rub 5.03 3.53 2.50 4.08 5.05   15.7
BV/share, rub -20.2 -21.9 -20.0 -18.7 71.3   71.3
EBITDA margin, % ? 23.7% 23.5% 33.9% 24.9% 23.6%   26.5%
Net margin, % ? 17.2% 17.1% 25.6% 17.5% 17.3%   19.4%
FCF yield, % ? 12.8% 13.0% 10.4% 11.1% 11.3%   11.3%
ROE, % ? 19.7% 19.7% 20.2% 19.4% 19.3%   19.3%
ROA, % ? 3.61% 3.57% 3.77% 3.77% 3.80%   3.80%
P/E ? 10.3 9.74 10.4 9.74 9.27   9.27
P/FCF 7.80 7.70 9.58 9.02 8.87   8.87
P/S ? 1.88 1.76 2.01 1.89 1.80   1.80
P/BV ? -6.51 -5.68 -7.13 -7.46 1.95   1.95
EV/EBITDA ? -2.79 -3.13 -2.25 -2.59 8.24   8.24
Debt/EBITDA -10.3 -10.3 -9.90 -9.69 1.45   1.45
R&D/CAPEX, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
CAPEX/Revenue, % 0.79% 0.87% 6.43% 1.35% 1.60%   2.56%
Globe Life shareholders